TOP GUIDELINES OF HEMGENIX

Amount of qualified individuals: CDEC reviewed the uncertainty in the volume of individuals with moderately intense to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific professionals consulted by CADTH indicated that some sufferers who're labeled as acquiring delicate or average disease may have a serious bleeding ph